Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

FORC, DARA, MSI, VSH, DOW - Stock Report! April 12th 2011

|Includes: DWDP, MSI, Midatech Pharma PLC (MTP), VSH



Force Energy Corp. (OTC.BB:FORC) maintains a 50% working interest in County Line Energy Corp. interest in the Hayter Well (10D Hayter 10-8-40-1 W4M) located in Alberta, Canada. The well was spudded in January 2007 and drilled to a total depth. The well logs revealed a gas zone of 4 to 5 meters of thickness in a shallow zone and a heavy oil pay zone of 2 meters of thickness in the target Dina Sand zone. Although the results in the Dina sand were lower than expected and a decision was made to case the well in 2007, should prices rise in the future, the Hayter could produce an economic well.

County Line Energy completed a $650,000 3D seismic program covering nine sections of land in pursuit of a potential multi well heavy oil drilling opportunity. The geological model was based on interpretation from a previous well, which produced 16,000 barrels of heavy oil. The seismic program was designed to determine whether the structure found in this well existed to a larger extent on the subject property. The 3D seismic revealed an extremely large anomaly with similar characteristics. The nature of this large anomaly suggested that a multi well drilling opportunity might exist. Although this well will likely be completed as a producing well the results of the drilling have negated the ultimate potential of the Hayter property.

The current oil price spike started back in February when the rebellion in Libya's oil fields put a stop to the country's daily exports of 1.5 million barrels of crude. That has caused oil speculators to push up the price.

Read more at:

DARA BioSciences Reports That SurgiVision Has Completed a Commercial Alliance With Brainlab AG!

DARA Presently Owns Over 500,000 Shares and Warrants of SurgiVision, Inc.

DARA BioSciences, Inc. (Nasdaq:DARA), reported today that SurgiVision, Inc., a privately held company, and Brainlab AG, announced on April 11 a collaboration aimed at integrating SurgiVision's ClearPoint(NYSE:R) product line with Brainlab's iMRI product line, with particular focus on local delivery of drugs and other therapeutic agents to precision targets in the brain under magnetic resonance imaging (MRI) guidance. DARA presently owns over 500,000 shares and warrants of SurgiVision.

Last June, SurgiVision received 510(k) clearance from the Food and Drug Administration (FDA) to market their ClearPoint system in the United States for general neurological interventional procedures.

Read more at: